141 – 150 of 247
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Response criteria for rheumatoid arthritis in clinical practice - how useful are they?
- Contribution to journal › Article
-
Mark
No increase of severe infections in RA patients treated with TNF-blockers
(2005) Annual European Congress of Rheumatology, 2005 In Annals of the Rheumatic Diseases 64(Suppl. 3). p.461-462
- Contribution to journal › Published meeting abstract
-
Mark
Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales
- Contribution to journal › Letter
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
- Contribution to journal › Article
-
Mark
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
- Contribution to journal › Article
-
Mark
Prognostic laboratory markers of joint damage in rheumatoid arthritis.
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2004
-
Mark
Hormone replacement therapy, calcium and vitamin D-3 versus calcium and vitamin D-3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
- Contribution to journal › Article
-
Mark
Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures.
- Contribution to journal › Article
-
Mark
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al
- Contribution to journal › Letter
